Citation Impact
Citing Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
miR-15 and miR-16 induce apoptosis by targeting BCL2
2005 Standout
Gene expression profiling predicts clinical outcome of breast cancer
2002 StandoutNature
Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B‐cell lymphoma
2002
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2008 Standout
Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study
2006
The Clinical Significance of CD10 Antigen Expression in Diffuse Large B-Cell Lymphoma
2001
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas
2004
High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
1998
bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related.
1998
Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins.
1998
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Clinicopathologic Analysis of CD10+ and CD10– Diffuse Large B-Cell Lymphoma
2001
Clinical Epidemiological Quality in Molecular Genetic Research
1999
The IL-7 Receptor Controls the Accessibility of the TCRγ Locus by Stat5 and Histone Acetylation
2001 StandoutNobel
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Targeting cancer-initiating cell drug-resistance: a roadmap to a new-generation of cancer therapies?
2011
Large language models in medicine
2023 Standout
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
2002 Standout
Bcl-2 functions in an antioxidant pathway to prevent apoptosis
1993 Standout
Primary Cutaneous Diffuse Large B-Cell Lymphoma
2002
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
2002 Standout
Prediction of Survival in Diffuse Large-B-Cell Lymphoma Based on the Expression of Six Genes
2004
The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis
2001
Targeting multidrug resistance in cancer
2006 Standout
Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)
2003
A molecular signature of metastasis in primary solid tumors
2002 Standout
Signalling pathways of the TNF superfamily: a double-edged sword
2003 Standout
Immunohistochemical Expression Patterns of Germinal Center and Activation B-cell Markers Correlate With Prognosis in Diffuse Large B-cell Lymphoma
2004
Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance
2003
Apoptosis
2002 Standout
STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells
1999
Hematopoietic Stem-Cell Transplantation
2006 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Death and anti-death: tumour resistance to apoptosis
2002 Standout
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Reflecting on 25 years with MYC
2008 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
A Multifaceted benchmarking of synthetic electronic health record generation models
2022
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
The Myc oncoprotein as a therapeutic target for human cancer
2006
Negative regulation of bcl-2 expression by p53 in hematopoietic cells
2001
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response
2004
Cancer and ageing: a nexus at several levels
2005
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2007 Standout
Topoisomerase I inhibitors: camptothecins and beyond
2006 Standout
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
1993 Standout
CD10 and Bcl10 expression in diffuse large B‐cell lymphoma: CD10 is a marker of improved prognosis
2001
Presence of somatic hypermutation and activation‐induced cytidine deaminase in acute lymphoblastic leukemia L2 with t(14;18)(q32;q21)
2004
Prognostic clinicopathologic factors, including immunologic expression in diffuse large B‐cell lymphomas
1999
Rearrangements of Bcl-1, Bcl-2, Bcl-6, and C-Myc in Diffuse Large B-Cell Lymphomas
2001
CD10 and BCL-6 Expression in Paraffin Sections of Normal Lymphoid Tissue and B-Cell Lymphomas
2000
Prognostic Significance of Ki-67 Nuclear Proliferative Antigen, bcl-2 Protein, and p53 Expression in Follicular and Diffuse Large B-Cell Lymphoma
2001
Primary and Secondary Cutaneous Diffuse Large B-Cell Lymphomas
2003
Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma
2001
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
2007
Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice
2007 StandoutNobel
Prognostic significance of survivin expression in diffuse large B-cell lymphomas.
2000
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP
2006 Standout
The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
2007 Standout
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
Clonal B cells in patients with hepatitis C virus–associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset
2011 StandoutNobel
Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte
2005 Standout
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Nonimmunoglobulin (non-Ig)/BCL6gene fusion in diffuse large B-cell lymphoma results in worse prognosis than Ig/BCL6
2000
Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma
2006
Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma
2006 Standout
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry
2002
Transcriptional control of human p53-regulated genes
2008 Standout
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
1993
Four faces of cellular senescence
2011 Standout
Prognostic Significance of Bcl-2 Protein Expression and Bcl-2 Gene Rearrangement in Diffuse Aggressive Non-Hodgkin's Lymphoma
1997
Nonimmunoglobulin (non-Ig)/BCL6gene fusion in diffuse large B-cell lymphoma results in worse prognosis than Ig/BCL6
2000
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Cell cycle deregulation in B-cell lymphomas
2003
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
The biology and treatment of acute lymphoblastic leukemia in adults
1995
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2005 Standout
Risk-assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas.
2001
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
2009 StandoutScience
Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach
2005
Prognostic Significance of Bcl-2 Protein Expression and Bcl-2 Gene Rearrangement in Diffuse Aggressive Non-Hodgkin's Lymphoma
1997
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma
2005
The Role of B7 Costimulation in CD4/CD8 T Cell Homeostasis
2000 StandoutNobel
Phase II Study of Rituximab in Combination With CHOP Chemotherapy in Patients With Previously Untreated, Aggressive Non-Hodgkin’s Lymphoma
2001
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma
2002
BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphoma
2005
Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma
2009
Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma
2004
VH Gene Analysis of Primary Cutaneous B-Cell Lymphomas: Evidence for Ongoing Somatic Hypermutation and Isotype Switching
1998
Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma
2002
Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice.
1992
Bcl-2 and the regulation of programmed cell death
1994 Standout
Works of M Krámer being referenced
Differentiation of follicular lymphoma cells after autologous bone marrow transplantation and haematopoietic growth factor treatment
1995
Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study.
1996
Mantle-cell lymphoma: a population-based clinical study.
1996
Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia:
2004
De novo acute B-cell leukemia with translocation t(14;18): an entity with a poor prognosis.
1991
Synthea: An approach, method, and software mechanism for generating synthetic patients and the synthetic electronic health care record
2017
Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma
1998
CHOP Compared With CHOP Plus Granulocyte Colony-Stimulating Factor in Elderly Patients With Aggressive Non-Hodgkin’s Lymphoma
2003
Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma
1998
Histological conversion of follicular lymphoma with structural alterations of t(14;18) and immunoglobin genes.
1995